Reply to correspondence on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway” Eun Ji Jang, Pil Soo Sung Clinical and Molecular Hepatology.2026; 32(1): e115. CrossRef
Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography: A Potential Imaging Biomarker for Predicting Response to Combination Immunotherapy in Hepatocellular Carcinoma Masatoshi Kudo Liver Cancer.2025; 14(5): 511. CrossRef
Correspondence to editorial on “CD36 Promotes iron accumulation and dysfunction in CD8+ T cells via the p38-CEBPB-TfR1 axis in early-stage hepatocellular carcinoma” Yifei Qin, Peng Lin, Huijie Bian, Zhi-Nan Chen, Jiao Wu Clinical and Molecular Hepatology.2026; 32(1): e75. CrossRef
Reprogrammed Lipid Metabolism as a Gatekeeper of Hepatocarcinogenesis: from Enzyme Regulation to Precision Therapy Luxi Yang, Jing Yang, Zhonghong Xiong, Jinsen Wei, Xiaojuan Jiang, Huili Ye, Yumin Li Current Oncology Reports.2026;[Epub] CrossRef
Distinct tumor immune microenvironment modulation by anti-PD-1/PD-L1, VEGF, and CTLA-4 blockade provides a rationale for triplet therapy in hepatocellular carcinoma Hideki Iwamoto, Hironori Koga, Takumi Kawaguchi Clinical and Molecular Hepatology.2026; 32(1): e38. CrossRef
Correspondence to editorial on “Integrated molecular characterization of sarcomatoid hepatocellular carcinoma” Rong-Qi Sun, Shao-Lai Zhou Clinical and Molecular Hepatology.2025; 31(2): e192. CrossRef
Curative response to combined targeted-immunotherapy for post-hepatectomy lymph node metastasis in sarcomatoid hepatocellular carcinoma: case report and literature review Pan Liu, Song Zhang, Xiao-Ming Xin, Min Jing, Lie-Dong Wen, Xin Xiang, Shun-Hai Liu Frontiers in Oncology.2025;[Epub] CrossRef
Distinct tumor immune microenvironment modulation by anti-PD-1/PD-L1, VEGF, and CTLA-4 blockade provides a rationale for triplet therapy in hepatocellular carcinoma Hideki Iwamoto, Hironori Koga, Takumi Kawaguchi Clinical and Molecular Hepatology.2026; 32(1): e38. CrossRef
Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial” Sun Young Yim, Sung Hwan Lee, Ji Hoon Kim, Sunyoung S Lee, Ahmed O Kaseb, Ju-Seog Lee Clinical and Molecular Hepatology.2025; 31(1): e84. CrossRef
T lymphocyte-based immune response and therapy in hepatocellular carcinoma: focus on TILs and CAR-T cells Thikra Majid Muhammed, Saade Abdalkareem Jasim, Ahmed Hussein Zwamel, Safia Obaidur Rab, Suhas Ballal, Abhayveer Singh, Anima Nanda, Subhashree Ray, Ahmed Hjazi, Hatif Abdulrazaq Yasin Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(8): 10007. CrossRef
Genetic insights into sarcomatoid hepatocellular carcinoma: Critical role of ARID2 in pathogenesis and immune feature: Editorial on “Integrated molecular characterization of sarcomatoid hepatocellular carcinoma” Naoshi Nishida Clinical and Molecular Hepatology.2025; 31(2): 635. CrossRef
Addressing the Complexities of Pre-Liver Transplant Immune Checkpoint Inhibitors for Hepatocellular Carcinoma: A Response to Recent Commentaries Mohammad Saeid Rezaee-Zavareh, Zhiyong Guo, Ju Dong Yang Journal of Hepatology.2024;[Epub] CrossRef
The tumor microenvironment generally shows a substantial immunosuppressive activity in hepatocellular carcinoma (HCC), accounting for the suboptimal efficacy of immune-based treatments for this difficult-to-treat cancer. The crosstalk between tumor cells and various cell types in the tumor microenvironment is strongly related to HCC progression and treatment resistance. Monocytes are recruited to the HCC tumor microenvironment by various factors and become tumor-associated macrophages (TAMs) with distinct phenotypes. TAMs often contribute to weakened tumor-specific immune responses and a more aggressive phenotype of malignancy. Recent single-cell RNA-sequencing data have demonstrated the central roles of specific TAMs in tumorigenesis and treatment resistance by their interactions with various cell populations in the HCC tumor microenvironment. This review focuses on the roles of TAMs and the crosstalk between TAMs and neighboring cell types in the HCC tumor microenvironment.
Citations
Citations to this article as recorded by
Tumor-associated macrophages in hepatocellular carcinoma: Cellular plasticity and therapy resistance in crosstalk Tianhao Zhang, Xi Zhao, Tingting Gao, Fang Ma Journal of Pharmaceutical Analysis.2026; 16(1): 101384. CrossRef
Signalling pathways in hepatocellular carcinoma (HCC) metastasis and invasion: Molecular mechanisms and therapeutic implications Jayanta Das, Bhupen Barman, Phulen Sarma, Bipul Kumar Das, Rajiv Chetia, Partha Pratim Kalita Biochemistry and Biophysics Reports.2026; 45: 102403. CrossRef
RNA splicing dysregulation in hepatocellular carcinoma: Molecular mechanisms, therapeutic targets, and intervention strategies—A comprehensive review Shuai Xiong, Lei Hu, Yun-Yang Sun, Wei Huang, Xiao-Yu Hu Biomedicine & Pharmacotherapy.2026; 195: 119025. CrossRef
Construction of an Oxidative Stress Risk Model to Analyze the Correlation Between Liver Cancer and Tumor Immunity Ying Liu, Yufeng Li, Li Chen, Weina Zha, Jing Zhang, Kun Wang, Chunhai Hao, Jianhe Gan Current Cancer Drug Targets.2025; 25(1): 49. CrossRef
The multifaceted roles of macrophages in the transition from hepatitis to hepatocellular carcinoma: From mechanisms to therapeutic strategies Shuairan Zhang, Hang Dong, Xiuli Jin, Jing Sun, Yiling Li Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2025; 1871(3): 167676. CrossRef
Interactions between the metabolic reprogramming of liver cancer and tumor microenvironment Haoqiang Yang, Jinghui Li, Yiting Niu, Tao Zhou, Pengyu Zhang, Yang Liu, Yanjun Li Frontiers in Immunology.2025;[Epub] CrossRef
C-reactive protein to albumin ratio combined with the Systemic Inflammatory Response Index predicts the prognosis of patients undergoing radical hepatectomy Shao-Long Lu, Qing-Yuan Zhang, Yuan-Quan Zhao, Hua-Lin Wu, Jie Lin, Peng Zhu, Zheng-Jun Qin, Xiao-Bo Wang, Jie Chen BMC Cancer.2025;[Epub] CrossRef
The PNPLA3 I148M variant is associated with immune cell infiltration and advanced fibrosis in MASLD: a prospective genotype–phenotype study Jaejun Lee, Jung Hoon Cha, Hee Sun Cho, Keungmo Yang, Hyun Yang, Heechul Nam, Mi Young Byun, Seok Keun Cho, Jinsung Park, Hyuk Wan Ko, Seong Wook Yang, Pil Soo Sung, Si Hyun Bae Journal of Gastroenterology.2025; 60(10): 1284. CrossRef
Periostin-integrin signaling in hepatocellular carcinoma: from biological function to clinical application Jun Lei, Yong Liu, Shuai Yuan, Xiaxia Yuan, Qi Yuan Frontiers in Cell and Developmental Biology.2025;[Epub] CrossRef
Relationships Among Serological Indicators and In Vitro High-Throughput Drug Sensitivity Screening Results in Patients with Hepatocellular Carcinoma Xu Feng, Guo-Ying Feng, Jie Tao, Yu-Pei Ao, Xin-Hua Wu, Shi-Guai Qi, Zheng-Rong Shi, Ling-Yun Gao Combinatorial Chemistry & High Throughput Screening.2025; 28(11): 1927. CrossRef
Characterizing ligand-receptor interactions and unveiling the pro-tumorigenic role of CCL16-CCR1 axis in the microenvironment of hepatocellular carcinoma Zongbo Dai, Yu Wang, Ning Sun, Chengshuo Zhang Frontiers in Immunology.2024;[Epub] CrossRef
Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease Tongguo Miao, Xianzhe Lou, Shiming Dong, Xiaoxiao Zhang, Weiwei Guan, Ying Zhang, Lu Li, Xiwei Yuan, Dong Ma, Yuemin Nan Journal of Hepatocellular Carcinoma.2024; Volume 11: 145. CrossRef
Immune microenvironment in hepatocellular carcinoma: current concepts and the role of blockade of immune checkpoints E.L. Bueverova, O.Yu. Zolnikova, M.A. Paltzev Molekulyarnaya Meditsina (Molecular medicine).2024; 22(1): 3. CrossRef
Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of HCC Jong Geun Park, Pu Reun Roh, Min Woo Kang, Sung Woo Cho, Suhyun Hwangbo, Hae Deok Jung, Hyun Uk Kim, Ji Hoon Kim, Jae-Sung Yoo, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Young Kyoung You, Ho Joong Choi, Jae Yong Ryu, Pil Soo Sung Hepatology.2024; 80(5): 1074. CrossRef
Consistent efficacy of hepatic artery infusion chemotherapy irrespective of PD‑L1 positivity in unresectable hepatocellular carcinoma Ji Kim, Young Kim, Hee-Chul Nam, Chang-Wook Kim, Jae-Sung Yoo, Ji Han, Jeong Jang, Jong Choi, Seung Yoon, Ho Jong Chun, Jung Oh, Suho Kim, Sung Lee, Pil Sung Oncology Letters.2024;[Epub] CrossRef
Liver cancer from the perspective of single-cell sequencing: a review combined with bibliometric analysis Yanwei Ji, Qi An, Xinyu Wen, Zhou Xu, Zhengyuan Xia, Zhongyuan Xia, Qinyong Hu, Shaoqing Lei Journal of Cancer Research and Clinical Oncology.2024;[Epub] CrossRef
Machine learning model reveals roles of interferon‑stimulated genes in sorafenib‑resistant liver cancer Deok Seo, Ji Park, Hee Jung, Min Kang, Byung Kang, Dong Lee, Jae Lee, Seung Yoon, Jeong Jang, Jae Ahn, Pil Sung Oncology Letters.2024;[Epub] CrossRef
Dynamic Peripheral T-Cell Analysis Identifies On-Treatment Prognostic Biomarkers of Atezolizumab plus Bevacizumab in Hepatocellular Carcinoma Ji Won Han, Min Woo Kang, Soon Kyu Lee, Hyun Yang, Ji Hoon Kim, Jae-Sung Yoo, Hee Sun Cho, Eun Ji Jang, Deok Hwa Seo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung Liver Cancer.2024; : 1. CrossRef
Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis Jung Hoon Cha, Na Ri Park, Sung Woo Cho, Heechul Nam, Hyun Yang, Eun Sun Jung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung, Si Hyun Bae Frontiers in Immunology.2024;[Epub] CrossRef
Recent Advances in Immune-based Therapy for Hepatocellular Carcinoma Kyung Won Park, Tae Hoon Park, Eun Ji Jang, Pil Soo Sung Journal of Digestive Cancer Research.2024; 12(2): 115. CrossRef
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi, Rosalba D’Alessandro, Giorgio Frega, Giovanni Brandi, Endrit Shahini, Raffaele Cozzolongo, Claudio Lotesoriere, Gianluigi Giannelli Cancers.2024; 16(20): 3542. CrossRef
The Role of Macrophages in Hepatocellular Carcinoma and Their Therapeutic Potential Megan E. Bannister, Devnandan A. Chatterjee, Shishir Shetty, Daniel A. Patten International Journal of Molecular Sciences.2024; 25(23): 13167. CrossRef
Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab Jaejun Lee, Jae-Sung Yoo, Ji Hoon Kim, Dong Yeup Lee, Keungmo Yang, Bohyun Kim, Joon-Il Choi, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ji Won Han, Pil Soo Sung Frontiers in Immunology.2024;[Epub] CrossRef
An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation Soon Kyu Lee, Jong Young Choi, Eun Sun Jung, Jung Hyun Kwon, Jeong Won Jang, Si Hyun Bae, Seung Kew Yoon International Journal of Molecular Sciences.2023; 24(5): 5002. CrossRef
Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data Min Jung Kwon, Soy Chang, Ji Hoon Kim, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung Frontiers in Oncology.2023;[Epub] CrossRef
Higher Number of Tumor-Infiltrating PD-L1+ Cells Is Related to Better Response to Multikinase Inhibitors in Hepatocellular Carcinoma Ji Won Han, Ji Hoon Kim, Dong Hyun Kim, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jaegyoon Ahn, Hyun Yang, Pil Soo Sung Diagnostics.2023; 13(8): 1453. CrossRef
IL-8-induced CXCR2 down-regulation in circulating monocytes in hepatocellular carcinoma is partially dependent on MAGL Chong Zhong Liu, Xing Bao Liu, Jun Sun, Chao Qun Yu, Jing Chun Yao, Zhong Liu, Jing Cheng Hao BMC Cancer.2023;[Epub] CrossRef
Isolation and characterization of cancer-associated fibroblasts in the tumor microenvironment of hepatocellular carcinoma Kyoungdo Mun, Jiwon Han, Pureun Roh, Jonggeun Park, Gahee Kim, Wonhee Hur, Jeongwon Jang, Jongyoung Choi, Seungkew Yoon, Youngkyoung You, Hojoong Choi, Pilsoo Sung Journal of Liver Cancer.2023; 23(2): 341. CrossRef
Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma Aloña Agirre-Lizaso, Maider Huici-Izagirre, Josu Urretabizkaia-Garmendia, Pedro M. Rodrigues, Jesus M. Banales, Maria J. Perugorria Cancers.2023; 15(20): 4977. CrossRef
Early C‐reactive Protein Kinetics Predict Response to Immune Checkpoint Blockade in Unresectable Hepatocellular Carcinoma Qiuying Qin, Xiaoxuan Kou, Yuanyuan Zheng, Fei Zhou, Xiaoyong Zhang, Hongyan Liu Journal of Hepatocellular Carcinoma.2023; Volume 10: 2009. CrossRef
Oxoaporphine Pr(III) complex inhibits hepatocellular carcinoma progression and metastasis by disrupting tumor cell–macrophage crosstalk Li Li, Wen-Tao Zuo, Hui Liu, Lan-Shan Liao, Wen-Ying Shen, Zhen-Feng Chen, Hong Liang Biomedicine & Pharmacotherapy.2023; 169: 115849. CrossRef
The role of tumor‐associated macrophages in hepatocellular carcinoma progression: A narrative review Xinyi Zhang, Chao Yu, Siqi Zhao, Min Wang, Longcheng Shang, Jin Zhou, Yong Ma Cancer Medicine.2023; 12(24): 22109. CrossRef
A Unique Immune-Related Gene Signature Represents Advanced Liver Fibrosis and Reveals Potential Therapeutic Targets Pil-Soo Sung, Chang-Min Kim, Jung-Hoon Cha, Jin-Young Park, Yun-Suk Yu, Hee-Jung Wang, Jin-Kyeoung Kim, Si-Hyun Bae Biomedicines.2022; 10(1): 180. CrossRef
Intrahepatic inflammatory IgA+PD-L1high monocytes in hepatocellular carcinoma development and immunotherapy Pil Soo Sung, Dong Jun Park, Pu Reun Roh, Kyoung Do Mun, Sung Woo Cho, Gil Won Lee, Eun Sun Jung, Sung Hak Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Jonghwan Choi, Jaegyoon Ahn, Seung Kew Yoon Journal for ImmunoTherapy of Cancer.2022; 10(5): e003618. CrossRef
The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy Zhang Guizhen, Ji Guanchang, Liu Liwen, Wang Huifen, Ren Zhigang, Sun Ranran, Yu Zujiang Frontiers in Endocrinology.2022;[Epub] CrossRef
The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies Ruixue Bai, Yunong Li, Lingyan Jian, Yuehui Yang, Lin Zhao, Minjie Wei Molecular Cancer.2022;[Epub] CrossRef
Multiplexed Digital Spatial Protein Profiling Reveals Distinct Phenotypes of Mononuclear Phagocytes in Livers with Advanced Fibrosis Jaejun Lee, Chang Min Kim, Jung Hoon Cha, Jin Young Park, Yun Suk Yu, Hee Jung Wang, Pil Soo Sung, Eun Sun Jung, Si Hyun Bae Cells.2022; 11(21): 3387. CrossRef
Multidisciplinary approach for hepatocellular carcinoma arising from cirrhotic liver with Budd-Chiari syndrome: a case report Sangmi Kim, Ji Hoon Kim, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung Journal of Liver Cancer.2022; 22(2): 202. CrossRef
Tenofovir alafenamide alleviates nonalcoholic steatohepatitis in mice by blocking the phosphorylation of AKT in intrahepatic mononuclear phagocytes Pu Reun Roh, Sung Min Kim, Byung-Yoon Kang, Kyoung Do Mun, Jong Geun Park, Min Woo Kang, Wonhee Hur, Ji Won Han, Heechul Nam, Seung Kew Yoon, Pil Soo Sung Biomedicine & Pharmacotherapy.2022; 156: 113952. CrossRef
Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities Qingqing Xie, Pengfei Zhang, Yuanyuan Wang, Wuxuan Mei, Changchun Zeng Frontiers in Oncology.2022;[Epub] CrossRef
Blood-based biomarkers for immune-based therapy in advanced HCC: Promising but a long way to go Pil Soo Sung, Isaac Kise Lee, Pu Reun Roh, Min Woo Kang, Jaegyoon Ahn, Seung Kew Yoon Frontiers in Oncology.2022;[Epub] CrossRef
First
Prev
